StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$143.28−0.75 (-0.52%)

Close on Nov 17, 2026Market cap $19.23BP/E –Yield –

Guardant Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Guardant Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$185.19M. For fiscal 2025 it was -$184.76M. The highest annual figure on record is -$36.71M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$184.76M–
FY2024Dec 31, 2024-$239.86M–
FY2023Dec 31, 2023-$324.98M–
FY2022Dec 31, 2022-$309.46M–
FY2021Dec 31, 2021-$209.02M–
FY2020Dec 31, 2020-$103.93M–
FY2019Dec 31, 2019-$47.13M–
FY2018Dec 31, 2018-$72.19M–
FY2017Dec 31, 2017-$72.24M–
FY2016Dec 31, 2016-$36.71M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$57.78M–
Q1 FY2026Mar 31, 2026-$65.62M–
Q4 FY2025Dec 31, 2025-$26.37M–
Q3 FY2025Sep 30, 2025-$35.41M–
Q2 FY2025Jun 30, 2025-$60.29M–
Q1 FY2025Mar 31, 2025-$62.69M–
Q4 FY2024Dec 31, 2024-$64.51M–
Q3 FY2024Sep 30, 2024-$51.06M–
Q2 FY2024Jun 30, 2024-$94.00M–
Q1 FY2024Mar 31, 2024-$30.28M–
Q4 FY2023Dec 31, 2023-$78.73M–
Q3 FY2023Sep 30, 2023-$77.79M–
Q2 FY2023Jun 30, 2023-$94.02M–
Q1 FY2023Mar 31, 2023-$74.44M–
Q4 FY2022Dec 31, 2022-$90.75M–
Q3 FY2022Sep 30, 2022-$78.16M–
Q2 FY2022Jun 30, 2022-$111.94M–
Q1 FY2022Mar 31, 2022-$28.62M–
Q4 FY2021Dec 31, 2021-$76.99M–
Q3 FY2021Sep 30, 2021-$53.15M–
Q2 FY2021Jun 30, 2021-$62.59M–
Q1 FY2021Mar 31, 2021-$16.29M–
Q4 FY2020Dec 31, 2020-$59.22M–
Q3 FY2020Sep 30, 2020-$8.06M-698.1%
Q2 FY2020Jun 30, 2020-$23.37M–
Q1 FY2020Mar 31, 2020-$13.28M–
Q4 FY2019Dec 31, 2019-$30.34M–
Q3 FY2019Sep 30, 2019$1.35M–
Q2 FY2019Jun 30, 2019-$13.84M–
Q1 FY2019Mar 31, 2019-$4.30M–
Q4 FY2018Dec 31, 2018-$26.54M–
Q3 FY2018Sep 30, 2018-$22.05M–
Q2 FY2018Jun 30, 2018-$17.04M–
Q1 FY2018Mar 31, 2018-$6.56M–
Q4 FY2017Dec 31, 2017-$17.99M–

More Guardant Health figures

See a number that looks wrong?